nodes	percent_of_prediction	percent_of_DWPC	metapath
Flumazenil—Tachycardia—Melphalan—ovarian cancer	0.00319	0.00319	CcSEcCtD
Flumazenil—Malaise—Vinorelbine—ovarian cancer	0.00316	0.00316	CcSEcCtD
Flumazenil—Ventricular extrasystoles—Doxorubicin—ovarian cancer	0.00315	0.00315	CcSEcCtD
Flumazenil—Vertigo—Vinorelbine—ovarian cancer	0.00315	0.00315	CcSEcCtD
Flumazenil—Ataxia—Docetaxel—ovarian cancer	0.00312	0.00312	CcSEcCtD
Flumazenil—Palpitations—Vinorelbine—ovarian cancer	0.00309	0.00309	CcSEcCtD
Flumazenil—Feeling abnormal—Chlorambucil—ovarian cancer	0.00309	0.00309	CcSEcCtD
Flumazenil—Ventricular tachycardia—Epirubicin—ovarian cancer	0.00308	0.00308	CcSEcCtD
Flumazenil—Hiccups—Epirubicin—ovarian cancer	0.00308	0.00308	CcSEcCtD
Flumazenil—Injection site reaction—Epirubicin—ovarian cancer	0.00306	0.00306	CcSEcCtD
Flumazenil—Hypotension—Melphalan—ovarian cancer	0.00306	0.00306	CcSEcCtD
Flumazenil—Cough—Vinorelbine—ovarian cancer	0.00305	0.00305	CcSEcCtD
Flumazenil—Hypertension—Vinorelbine—ovarian cancer	0.00302	0.00302	CcSEcCtD
Flumazenil—Paraesthesia—Topotecan—ovarian cancer	0.003	0.003	CcSEcCtD
Flumazenil—Salivary hypersecretion—Epirubicin—ovarian cancer	0.00299	0.00299	CcSEcCtD
Flumazenil—Urticaria—Chlorambucil—ovarian cancer	0.00298	0.00298	CcSEcCtD
Flumazenil—Chest pain—Vinorelbine—ovarian cancer	0.00298	0.00298	CcSEcCtD
Flumazenil—Dyspnoea—Topotecan—ovarian cancer	0.00298	0.00298	CcSEcCtD
Flumazenil—Discomfort—Vinorelbine—ovarian cancer	0.00294	0.00294	CcSEcCtD
Flumazenil—Paraesthesia—Melphalan—ovarian cancer	0.00294	0.00294	CcSEcCtD
Flumazenil—Dyspnoea—Melphalan—ovarian cancer	0.00292	0.00292	CcSEcCtD
Flumazenil—Fatigue—Topotecan—ovarian cancer	0.00288	0.00288	CcSEcCtD
Flumazenil—Pain—Topotecan—ovarian cancer	0.00286	0.00286	CcSEcCtD
Flumazenil—Ventricular tachycardia—Doxorubicin—ovarian cancer	0.00285	0.00285	CcSEcCtD
Flumazenil—Hiccups—Doxorubicin—ovarian cancer	0.00285	0.00285	CcSEcCtD
Flumazenil—Injection site reaction—Doxorubicin—ovarian cancer	0.00283	0.00283	CcSEcCtD
Flumazenil—Fatigue—Melphalan—ovarian cancer	0.00282	0.00282	CcSEcCtD
Flumazenil—Pain—Melphalan—ovarian cancer	0.0028	0.0028	CcSEcCtD
Flumazenil—Tachycardia—Vinorelbine—ovarian cancer	0.00279	0.00279	CcSEcCtD
Flumazenil—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.00277	0.00277	CcSEcCtD
Flumazenil—Hypersensitivity—Chlorambucil—ovarian cancer	0.00276	0.00276	CcSEcCtD
Flumazenil—Bradycardia—Paclitaxel—ovarian cancer	0.00275	0.00275	CcSEcCtD
Flumazenil—Feeling abnormal—Topotecan—ovarian cancer	0.00275	0.00275	CcSEcCtD
Flumazenil—Asthenia—Chlorambucil—ovarian cancer	0.00269	0.00269	CcSEcCtD
Flumazenil—Hypoaesthesia—Paclitaxel—ovarian cancer	0.00269	0.00269	CcSEcCtD
Flumazenil—Abnormal vision—Epirubicin—ovarian cancer	0.00269	0.00269	CcSEcCtD
Flumazenil—Hypotension—Vinorelbine—ovarian cancer	0.00267	0.00267	CcSEcCtD
Flumazenil—Pruritus—Chlorambucil—ovarian cancer	0.00265	0.00265	CcSEcCtD
Flumazenil—Urticaria—Topotecan—ovarian cancer	0.00265	0.00265	CcSEcCtD
Flumazenil—Visual impairment—Paclitaxel—ovarian cancer	0.00261	0.00261	CcSEcCtD
Flumazenil—Urticaria—Melphalan—ovarian cancer	0.0026	0.0026	CcSEcCtD
Flumazenil—Thrombophlebitis—Epirubicin—ovarian cancer	0.00258	0.00258	CcSEcCtD
Flumazenil—Paraesthesia—Vinorelbine—ovarian cancer	0.00257	0.00257	CcSEcCtD
Flumazenil—Dyspnoea—Vinorelbine—ovarian cancer	0.00255	0.00255	CcSEcCtD
Flumazenil—Tinnitus—Paclitaxel—ovarian cancer	0.00252	0.00252	CcSEcCtD
Flumazenil—Flushing—Paclitaxel—ovarian cancer	0.00251	0.00251	CcSEcCtD
Flumazenil—Abnormal vision—Doxorubicin—ovarian cancer	0.00249	0.00249	CcSEcCtD
Flumazenil—Fatigue—Vinorelbine—ovarian cancer	0.00246	0.00246	CcSEcCtD
Flumazenil—Hypersensitivity—Topotecan—ovarian cancer	0.00246	0.00246	CcSEcCtD
Flumazenil—Pain—Vinorelbine—ovarian cancer	0.00244	0.00244	CcSEcCtD
Flumazenil—Chills—Paclitaxel—ovarian cancer	0.00243	0.00243	CcSEcCtD
Flumazenil—Arrhythmia—Paclitaxel—ovarian cancer	0.00242	0.00242	CcSEcCtD
Flumazenil—Hypersensitivity—Melphalan—ovarian cancer	0.00241	0.00241	CcSEcCtD
Flumazenil—Asthenia—Topotecan—ovarian cancer	0.0024	0.0024	CcSEcCtD
Flumazenil—Hot flush—Epirubicin—ovarian cancer	0.00239	0.00239	CcSEcCtD
Flumazenil—Thrombophlebitis—Doxorubicin—ovarian cancer	0.00239	0.00239	CcSEcCtD
Flumazenil—Vomiting—Chlorambucil—ovarian cancer	0.00239	0.00239	CcSEcCtD
Flumazenil—Menopausal symptoms—Epirubicin—ovarian cancer	0.00237	0.00237	CcSEcCtD
Flumazenil—Pruritus—Topotecan—ovarian cancer	0.00236	0.00236	CcSEcCtD
Flumazenil—Erythema—Paclitaxel—ovarian cancer	0.00235	0.00235	CcSEcCtD
Flumazenil—Feeling abnormal—Vinorelbine—ovarian cancer	0.00235	0.00235	CcSEcCtD
Flumazenil—Asthenia—Melphalan—ovarian cancer	0.00235	0.00235	CcSEcCtD
Flumazenil—Pruritus—Melphalan—ovarian cancer	0.00231	0.00231	CcSEcCtD
Flumazenil—Tension—Paclitaxel—ovarian cancer	0.00231	0.00231	CcSEcCtD
Flumazenil—Nervousness—Paclitaxel—ovarian cancer	0.00229	0.00229	CcSEcCtD
Flumazenil—Hypoaesthesia—Docetaxel—ovarian cancer	0.00228	0.00228	CcSEcCtD
Flumazenil—Urticaria—Vinorelbine—ovarian cancer	0.00227	0.00227	CcSEcCtD
Flumazenil—Diplopia—Epirubicin—ovarian cancer	0.00224	0.00224	CcSEcCtD
Flumazenil—Nausea—Chlorambucil—ovarian cancer	0.00223	0.00223	CcSEcCtD
Flumazenil—Vision blurred—Paclitaxel—ovarian cancer	0.00222	0.00222	CcSEcCtD
Flumazenil—Hot flush—Doxorubicin—ovarian cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Visual impairment—Docetaxel—ovarian cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Dizziness—Topotecan—ovarian cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Tremor—Paclitaxel—ovarian cancer	0.00221	0.00221	CcSEcCtD
Flumazenil—Affect lability—Epirubicin—ovarian cancer	0.0022	0.0022	CcSEcCtD
Flumazenil—Menopausal symptoms—Doxorubicin—ovarian cancer	0.00219	0.00219	CcSEcCtD
Flumazenil—Ill-defined disorder—Paclitaxel—ovarian cancer	0.00218	0.00218	CcSEcCtD
Flumazenil—Agitation—Paclitaxel—ovarian cancer	0.00216	0.00216	CcSEcCtD
Flumazenil—Flushing—Docetaxel—ovarian cancer	0.00213	0.00213	CcSEcCtD
Flumazenil—Vomiting—Topotecan—ovarian cancer	0.00212	0.00212	CcSEcCtD
Flumazenil—Malaise—Paclitaxel—ovarian cancer	0.00212	0.00212	CcSEcCtD
Flumazenil—Mood swings—Epirubicin—ovarian cancer	0.00212	0.00212	CcSEcCtD
Flumazenil—Vertigo—Paclitaxel—ovarian cancer	0.00212	0.00212	CcSEcCtD
Flumazenil—Rash—Topotecan—ovarian cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Hypersensitivity—Vinorelbine—ovarian cancer	0.00211	0.00211	CcSEcCtD
Flumazenil—Dermatitis—Topotecan—ovarian cancer	0.0021	0.0021	CcSEcCtD
Flumazenil—Ataxia—Epirubicin—ovarian cancer	0.0021	0.0021	CcSEcCtD
Flumazenil—Headache—Topotecan—ovarian cancer	0.00209	0.00209	CcSEcCtD
Flumazenil—Palpitations—Paclitaxel—ovarian cancer	0.00208	0.00208	CcSEcCtD
Flumazenil—Vomiting—Melphalan—ovarian cancer	0.00208	0.00208	CcSEcCtD
Flumazenil—Diplopia—Doxorubicin—ovarian cancer	0.00207	0.00207	CcSEcCtD
Flumazenil—Rash—Melphalan—ovarian cancer	0.00206	0.00206	CcSEcCtD
Flumazenil—Dermatitis—Melphalan—ovarian cancer	0.00206	0.00206	CcSEcCtD
Flumazenil—Chills—Docetaxel—ovarian cancer	0.00206	0.00206	CcSEcCtD
Flumazenil—Cough—Paclitaxel—ovarian cancer	0.00205	0.00205	CcSEcCtD
Flumazenil—Asthenia—Vinorelbine—ovarian cancer	0.00205	0.00205	CcSEcCtD
Flumazenil—Arrhythmia—Docetaxel—ovarian cancer	0.00205	0.00205	CcSEcCtD
Flumazenil—Affect lability—Doxorubicin—ovarian cancer	0.00204	0.00204	CcSEcCtD
Flumazenil—Hypertension—Paclitaxel—ovarian cancer	0.00203	0.00203	CcSEcCtD
Flumazenil—Pruritus—Vinorelbine—ovarian cancer	0.00202	0.00202	CcSEcCtD
Flumazenil—Chest pain—Paclitaxel—ovarian cancer	0.002	0.002	CcSEcCtD
Flumazenil—Anxiety—Paclitaxel—ovarian cancer	0.002	0.002	CcSEcCtD
Flumazenil—Erythema—Docetaxel—ovarian cancer	0.002	0.002	CcSEcCtD
Flumazenil—Nausea—Topotecan—ovarian cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Discomfort—Paclitaxel—ovarian cancer	0.00198	0.00198	CcSEcCtD
Flumazenil—Dry mouth—Paclitaxel—ovarian cancer	0.00196	0.00196	CcSEcCtD
Flumazenil—Mood swings—Doxorubicin—ovarian cancer	0.00196	0.00196	CcSEcCtD
Flumazenil—Ataxia—Doxorubicin—ovarian cancer	0.00194	0.00194	CcSEcCtD
Flumazenil—Nausea—Melphalan—ovarian cancer	0.00194	0.00194	CcSEcCtD
Flumazenil—Confusional state—Paclitaxel—ovarian cancer	0.00194	0.00194	CcSEcCtD
Flumazenil—Dizziness—Vinorelbine—ovarian cancer	0.00189	0.00189	CcSEcCtD
Flumazenil—Tachycardia—Paclitaxel—ovarian cancer	0.00188	0.00188	CcSEcCtD
Flumazenil—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00186	0.00186	CcSEcCtD
Flumazenil—Vomiting—Vinorelbine—ovarian cancer	0.00182	0.00182	CcSEcCtD
Flumazenil—Rash—Vinorelbine—ovarian cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Dermatitis—Vinorelbine—ovarian cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Hypotension—Paclitaxel—ovarian cancer	0.0018	0.0018	CcSEcCtD
Flumazenil—Headache—Vinorelbine—ovarian cancer	0.00179	0.00179	CcSEcCtD
Flumazenil—Palpitations—Docetaxel—ovarian cancer	0.00176	0.00176	CcSEcCtD
Flumazenil—Cough—Docetaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Flumazenil—Insomnia—Paclitaxel—ovarian cancer	0.00174	0.00174	CcSEcCtD
Flumazenil—Paraesthesia—Paclitaxel—ovarian cancer	0.00173	0.00173	CcSEcCtD
Flumazenil—Hypertension—Docetaxel—ovarian cancer	0.00172	0.00172	CcSEcCtD
Flumazenil—Drowsiness—Epirubicin—ovarian cancer	0.00172	0.00172	CcSEcCtD
Flumazenil—Dyspnoea—Paclitaxel—ovarian cancer	0.00171	0.00171	CcSEcCtD
Flumazenil—Somnolence—Paclitaxel—ovarian cancer	0.00171	0.00171	CcSEcCtD
Flumazenil—Chest pain—Docetaxel—ovarian cancer	0.0017	0.0017	CcSEcCtD
Flumazenil—Nausea—Vinorelbine—ovarian cancer	0.0017	0.0017	CcSEcCtD
Flumazenil—Dry mouth—Docetaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Fatigue—Paclitaxel—ovarian cancer	0.00166	0.00166	CcSEcCtD
Flumazenil—Sweating—Epirubicin—ovarian cancer	0.00165	0.00165	CcSEcCtD
Flumazenil—Pain—Paclitaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Confusional state—Docetaxel—ovarian cancer	0.00164	0.00164	CcSEcCtD
Flumazenil—Drowsiness—Doxorubicin—ovarian cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Tachycardia—Docetaxel—ovarian cancer	0.00159	0.00159	CcSEcCtD
Flumazenil—Feeling abnormal—Paclitaxel—ovarian cancer	0.00158	0.00158	CcSEcCtD
Flumazenil—Bradycardia—Epirubicin—ovarian cancer	0.00157	0.00157	CcSEcCtD
Flumazenil—Hypoaesthesia—Epirubicin—ovarian cancer	0.00154	0.00154	CcSEcCtD
Flumazenil—Sweating—Doxorubicin—ovarian cancer	0.00153	0.00153	CcSEcCtD
Flumazenil—Urticaria—Paclitaxel—ovarian cancer	0.00153	0.00153	CcSEcCtD
Flumazenil—Hypotension—Docetaxel—ovarian cancer	0.00152	0.00152	CcSEcCtD
Flumazenil—Visual impairment—Epirubicin—ovarian cancer	0.00149	0.00149	CcSEcCtD
Flumazenil—Insomnia—Docetaxel—ovarian cancer	0.00147	0.00147	CcSEcCtD
Flumazenil—Paraesthesia—Docetaxel—ovarian cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Bradycardia—Doxorubicin—ovarian cancer	0.00146	0.00146	CcSEcCtD
Flumazenil—Dyspnoea—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Somnolence—Docetaxel—ovarian cancer	0.00145	0.00145	CcSEcCtD
Flumazenil—Tinnitus—Epirubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Flushing—Epirubicin—ovarian cancer	0.00144	0.00144	CcSEcCtD
Flumazenil—Hypoaesthesia—Doxorubicin—ovarian cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Hypersensitivity—Paclitaxel—ovarian cancer	0.00142	0.00142	CcSEcCtD
Flumazenil—Fatigue—Docetaxel—ovarian cancer	0.0014	0.0014	CcSEcCtD
Flumazenil—Pain—Docetaxel—ovarian cancer	0.00139	0.00139	CcSEcCtD
Flumazenil—Chills—Epirubicin—ovarian cancer	0.00139	0.00139	CcSEcCtD
Flumazenil—Arrhythmia—Epirubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Flumazenil—Visual impairment—Doxorubicin—ovarian cancer	0.00138	0.00138	CcSEcCtD
Flumazenil—Asthenia—Paclitaxel—ovarian cancer	0.00138	0.00138	CcSEcCtD
Flumazenil—Pruritus—Paclitaxel—ovarian cancer	0.00136	0.00136	CcSEcCtD
Flumazenil—Erythema—Epirubicin—ovarian cancer	0.00135	0.00135	CcSEcCtD
Flumazenil—Feeling abnormal—Docetaxel—ovarian cancer	0.00134	0.00134	CcSEcCtD
Flumazenil—Tinnitus—Doxorubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Flushing—Doxorubicin—ovarian cancer	0.00133	0.00133	CcSEcCtD
Flumazenil—Tension—Epirubicin—ovarian cancer	0.00132	0.00132	CcSEcCtD
Flumazenil—Nervousness—Epirubicin—ovarian cancer	0.00131	0.00131	CcSEcCtD
Flumazenil—Chills—Doxorubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Arrhythmia—Doxorubicin—ovarian cancer	0.00128	0.00128	CcSEcCtD
Flumazenil—Dizziness—Paclitaxel—ovarian cancer	0.00127	0.00127	CcSEcCtD
Flumazenil—Vision blurred—Epirubicin—ovarian cancer	0.00127	0.00127	CcSEcCtD
Flumazenil—Ill-defined disorder—Epirubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Flumazenil—Erythema—Doxorubicin—ovarian cancer	0.00125	0.00125	CcSEcCtD
Flumazenil—Agitation—Epirubicin—ovarian cancer	0.00124	0.00124	CcSEcCtD
Flumazenil—Tension—Doxorubicin—ovarian cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Vomiting—Paclitaxel—ovarian cancer	0.00122	0.00122	CcSEcCtD
Flumazenil—Malaise—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Rash—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Dermatitis—Paclitaxel—ovarian cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Nervousness—Doxorubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Vertigo—Epirubicin—ovarian cancer	0.00121	0.00121	CcSEcCtD
Flumazenil—Headache—Paclitaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Flumazenil—Hypersensitivity—Docetaxel—ovarian cancer	0.0012	0.0012	CcSEcCtD
Flumazenil—Palpitations—Epirubicin—ovarian cancer	0.00119	0.00119	CcSEcCtD
Flumazenil—Cough—Epirubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Vision blurred—Doxorubicin—ovarian cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Asthenia—Docetaxel—ovarian cancer	0.00117	0.00117	CcSEcCtD
Flumazenil—Hypertension—Epirubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Flumazenil—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00116	0.00116	CcSEcCtD
Flumazenil—Pruritus—Docetaxel—ovarian cancer	0.00115	0.00115	CcSEcCtD
Flumazenil—Chest pain—Epirubicin—ovarian cancer	0.00115	0.00115	CcSEcCtD
Flumazenil—Agitation—Doxorubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Flumazenil—Anxiety—Epirubicin—ovarian cancer	0.00114	0.00114	CcSEcCtD
Flumazenil—Nausea—Paclitaxel—ovarian cancer	0.00114	0.00114	CcSEcCtD
Flumazenil—Discomfort—Epirubicin—ovarian cancer	0.00113	0.00113	CcSEcCtD
Flumazenil—Malaise—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Flumazenil—Dry mouth—Epirubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Flumazenil—Vertigo—Doxorubicin—ovarian cancer	0.00112	0.00112	CcSEcCtD
Flumazenil—Confusional state—Epirubicin—ovarian cancer	0.00111	0.00111	CcSEcCtD
Flumazenil—Palpitations—Doxorubicin—ovarian cancer	0.0011	0.0011	CcSEcCtD
Flumazenil—Cough—Doxorubicin—ovarian cancer	0.00109	0.00109	CcSEcCtD
Flumazenil—Dizziness—Docetaxel—ovarian cancer	0.00108	0.00108	CcSEcCtD
Flumazenil—Hypertension—Doxorubicin—ovarian cancer	0.00108	0.00108	CcSEcCtD
Flumazenil—Tachycardia—Epirubicin—ovarian cancer	0.00107	0.00107	CcSEcCtD
Flumazenil—Hyperhidrosis—Epirubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Chest pain—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Anxiety—Doxorubicin—ovarian cancer	0.00106	0.00106	CcSEcCtD
Flumazenil—Discomfort—Doxorubicin—ovarian cancer	0.00105	0.00105	CcSEcCtD
Flumazenil—Dry mouth—Doxorubicin—ovarian cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Vomiting—Docetaxel—ovarian cancer	0.00104	0.00104	CcSEcCtD
Flumazenil—Rash—Docetaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Flumazenil—Hypotension—Epirubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Flumazenil—Dermatitis—Docetaxel—ovarian cancer	0.00103	0.00103	CcSEcCtD
Flumazenil—Confusional state—Doxorubicin—ovarian cancer	0.00103	0.00103	CcSEcCtD
Flumazenil—Headache—Docetaxel—ovarian cancer	0.00102	0.00102	CcSEcCtD
Flumazenil—Insomnia—Epirubicin—ovarian cancer	0.000994	0.000994	CcSEcCtD
Flumazenil—Tachycardia—Doxorubicin—ovarian cancer	0.000992	0.000992	CcSEcCtD
Flumazenil—Paraesthesia—Epirubicin—ovarian cancer	0.000987	0.000987	CcSEcCtD
Flumazenil—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000983	0.000983	CcSEcCtD
Flumazenil—Dyspnoea—Epirubicin—ovarian cancer	0.00098	0.00098	CcSEcCtD
Flumazenil—Somnolence—Epirubicin—ovarian cancer	0.000977	0.000977	CcSEcCtD
Flumazenil—Nausea—Docetaxel—ovarian cancer	0.000968	0.000968	CcSEcCtD
Flumazenil—Hypotension—Doxorubicin—ovarian cancer	0.00095	0.00095	CcSEcCtD
Flumazenil—Fatigue—Epirubicin—ovarian cancer	0.000947	0.000947	CcSEcCtD
Flumazenil—Pain—Epirubicin—ovarian cancer	0.00094	0.00094	CcSEcCtD
Flumazenil—Insomnia—Doxorubicin—ovarian cancer	0.000919	0.000919	CcSEcCtD
Flumazenil—Paraesthesia—Doxorubicin—ovarian cancer	0.000913	0.000913	CcSEcCtD
Flumazenil—Dyspnoea—Doxorubicin—ovarian cancer	0.000906	0.000906	CcSEcCtD
Flumazenil—Feeling abnormal—Epirubicin—ovarian cancer	0.000905	0.000905	CcSEcCtD
Flumazenil—Somnolence—Doxorubicin—ovarian cancer	0.000904	0.000904	CcSEcCtD
Flumazenil—Fatigue—Doxorubicin—ovarian cancer	0.000876	0.000876	CcSEcCtD
Flumazenil—Urticaria—Epirubicin—ovarian cancer	0.000873	0.000873	CcSEcCtD
Flumazenil—Pain—Doxorubicin—ovarian cancer	0.000869	0.000869	CcSEcCtD
Flumazenil—Feeling abnormal—Doxorubicin—ovarian cancer	0.000838	0.000838	CcSEcCtD
Flumazenil—Hypersensitivity—Epirubicin—ovarian cancer	0.000809	0.000809	CcSEcCtD
Flumazenil—Urticaria—Doxorubicin—ovarian cancer	0.000808	0.000808	CcSEcCtD
Flumazenil—Asthenia—Epirubicin—ovarian cancer	0.000788	0.000788	CcSEcCtD
Flumazenil—Pruritus—Epirubicin—ovarian cancer	0.000777	0.000777	CcSEcCtD
Flumazenil—Hypersensitivity—Doxorubicin—ovarian cancer	0.000749	0.000749	CcSEcCtD
Flumazenil—Asthenia—Doxorubicin—ovarian cancer	0.000729	0.000729	CcSEcCtD
Flumazenil—Dizziness—Epirubicin—ovarian cancer	0.000727	0.000727	CcSEcCtD
Flumazenil—Pruritus—Doxorubicin—ovarian cancer	0.000719	0.000719	CcSEcCtD
Flumazenil—Vomiting—Epirubicin—ovarian cancer	0.000699	0.000699	CcSEcCtD
Flumazenil—Rash—Epirubicin—ovarian cancer	0.000693	0.000693	CcSEcCtD
Flumazenil—Dermatitis—Epirubicin—ovarian cancer	0.000692	0.000692	CcSEcCtD
Flumazenil—Headache—Epirubicin—ovarian cancer	0.000688	0.000688	CcSEcCtD
Flumazenil—Dizziness—Doxorubicin—ovarian cancer	0.000672	0.000672	CcSEcCtD
Flumazenil—Nausea—Epirubicin—ovarian cancer	0.000653	0.000653	CcSEcCtD
Flumazenil—Vomiting—Doxorubicin—ovarian cancer	0.000646	0.000646	CcSEcCtD
Flumazenil—Rash—Doxorubicin—ovarian cancer	0.000641	0.000641	CcSEcCtD
Flumazenil—Dermatitis—Doxorubicin—ovarian cancer	0.00064	0.00064	CcSEcCtD
Flumazenil—Headache—Doxorubicin—ovarian cancer	0.000637	0.000637	CcSEcCtD
Flumazenil—Nausea—Doxorubicin—ovarian cancer	0.000604	0.000604	CcSEcCtD
